Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis.

PubWeight™: 2.69‹?› | Rank: Top 1%

🔗 View Article (PMID 12591064)

Published in Am J Gastroenterol on February 01, 2003

Authors

Paolo Muratori1, Luigi Muratori, Rodolfo Ferrari, Fabio Cassani, Giampaolo Bianchi, Marco Lenzi, Luis Rodrigo, Antonio Linares, Dolores Fuentes, Francesco B Bianchi

Author Affiliations

1: Dipartimento di Medicina Interna, Cardioangiologia, Epatologia, Alma Mater Studiorum, Università di Bologna, Policlinico S. Orsola-Malpighi, Italy.

Articles citing this

Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol (2008) 1.34

Update on primary biliary cirrhosis. Dig Liver Dis (2010) 1.08

Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut (2005) 1.07

Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci (2010) 1.01

'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol (2004) 0.94

Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis. Hepatology (2011) 0.94

Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol (2009) 0.93

Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis. Clin Exp Immunol (2010) 0.90

Primary biliary cirrhosis and the nuclear pore complex. Autoimmun Rev (2012) 0.89

Primary biliary cirrhosis: what do autoantibodies tell us? World J Gastroenterol (2010) 0.89

The value of antinuclear antibodies in primary biliary cirrhosis. Clin Exp Med (2008) 0.88

Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis. Dig Dis Sci (2011) 0.87

Risk factors for hepatic decompensation in patients with primary biliary cirrhosis. World J Gastroenterol (2013) 0.86

Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. Am J Gastroenterol (2004) 0.86

Positive markers in AMA-negative PBC. Am J Gastroenterol (2003) 0.85

STAT4 gene polymorphisms are associated with susceptibility and ANA status in primary biliary cirrhosis. Dis Markers (2014) 0.82

Epitope-specific anti-nuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine-dependent. Clin Exp Immunol (2012) 0.82

Epstein-barr virus as a trigger of autoimmune liver diseases. Adv Virol (2012) 0.81

Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients. World J Gastroenterol (2010) 0.80

Autoantibodies in primary biliary cirrhosis: recent progress in research on the pathogenetic and clinical significance. World J Gastroenterol (2014) 0.80

The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis. Am J Clin Pathol (2015) 0.78

Overlap syndromes: an emerging diagnostic and therapeutic challenge. Saudi J Gastroenterol (2014) 0.78

The diagnosis and treatment of primary biliary cirrhosis. Korean J Hepatol (2011) 0.78

Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis. Auto Immun Highlights (2012) 0.78

Primary biliary cirrhosis: From bench to bedside. World J Gastrointest Pharmacol Ther (2015) 0.78

Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. Auto Immun Highlights (2013) 0.78

A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis. Expert Rev Mol Diagn (2016) 0.78

Differential detection of nuclear envelope autoantibodies in primary biliary cirrhosis using routine and alternative methods. BMC Gastroenterol (2010) 0.77

Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations. World J Gastroenterol (2015) 0.77

Presence of disease specific autoantibodies against liver sinusoidal cells in primary biliary cirrhosis. World J Hepatol (2013) 0.77

Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients. World J Gastroenterol (2012) 0.77

Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis. PLoS One (2014) 0.77

SP140L, an Evolutionarily Recent Member of the SP100 Family, Is an Autoantigen in Primary Biliary Cirrhosis. J Immunol Res (2015) 0.77

Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis? World J Gastroenterol (2012) 0.76

Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies. Auto Immun Highlights (2012) 0.75

Popular and unpopular infectious agents linked to primary biliary cirrhosis. Auto Immun Highlights (2012) 0.75

Primary Biliary Cirrhosis and Primary Sjögren's Syndrome: Insights for the Stomatologist. Case Rep Gastroenterol (2014) 0.75

Diagnostic value of anti-gp210 antibodies in primary biliary cirrhosis: a case-based review. BMJ Case Rep (2013) 0.75

Overlapping of primary biliary cirrhosis and small duct primary sclerosing cholangitis: first case report. J Clin Med Res (2012) 0.75

Diagnostic autoantibodies for autoimmune liver diseases. Clin Transl Immunology (2017) 0.75

Clinical significance and prevalence of anti-Saccharomyces cerevisiae antibody in Chinese patients with primary biliary cirrhosis. Clin Exp Med (2012) 0.75

Articles by these authors

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology (2003) 9.36

The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology (2007) 6.68

Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology (2008) 6.35

Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology (2003) 4.72

Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology (2005) 3.52

Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15

A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol (2005) 2.60

Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol (2009) 2.53

Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology (2003) 2.31

Laparoendoscopic single-site upper urinary tract surgery: assessment of postoperative complications and analysis of risk factors. Eur Urol (2011) 2.30

Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology (2006) 2.12

Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis (2005) 1.83

Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study. Arthritis Res Ther (2013) 1.81

The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol (2009) 1.70

Determinants of mean platelet volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes. Thromb Haemost (2008) 1.69

Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis (2003) 1.65

Muscle- and nerve-sparing bulbar urethroplasty: a new technique. Eur Urol (2008) 1.63

Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis (2006) 1.62

Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol (2004) 1.57

Thyroid autoimmunity in chronic idiopathic urticaria: implications for therapy. Am J Clin Dermatol (2002) 1.56

The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: nephrolithotomy in 189 patients with solitary kidneys. J Endourol (2011) 1.55

Dornier Lithotripter S 220 F EMSE: the first report of over 1000 treatments. Urology (2009) 1.48

Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol (2009) 1.42

Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. Clin Exp Rheumatol (2012) 1.41

Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40

Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol (2014) 1.40

Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci (2003) 1.37

Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study). Scand J Gastroenterol (2010) 1.33

Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain. Hepatology (2006) 1.32

Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis (2005) 1.30

Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol (2002) 1.23

Case-control study of toenail cadmium and prostate cancer risk in Italy. Sci Total Environ (2006) 1.21

Gastric endoscopic submucosal dissection assisted by a new traction method: the clip-band technique. A feasibility study in a porcine model (with video). Gastrointest Endosc (2011) 1.11

TNF-alpha -308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease. Am J Gastroenterol (2003) 1.11

A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology (2010) 1.10

HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology (2004) 1.09

Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population. Diabetes Care (2007) 1.09

Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci (2008) 1.08

Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice. Med Sci Monit (2004) 1.07

Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients. Am J Gastroenterol (2006) 1.07

Benign intratesticular schwannoma: a rare finding. Asian J Androl (2006) 1.06

Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients. J Clin Gastroenterol (2013) 1.03

Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology (2005) 1.02

Comparative evaluation between external phased array coil at 3 T and endorectal coil at 1.5 T: preliminary results. J Comput Assist Tomogr (2006) 1.02

Transcriptional regulation of MICA and MICB: a novel polymorphism in MICB promoter alters transcriptional regulation by Sp1. Eur J Immunol (2007) 1.02

CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility. PLoS One (2010) 1.01

Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis (2008) 1.00

Usefulness of an intensive bowel cleansing strategy for repeat colonoscopy after preparation failure. Dis Colon Rectum (2011) 1.00

Kaposi's sarcoma: an opportunistic infection by human herpesvirus-8 in ulcerative colitis. J Crohns Colitis (2010) 0.99

Celiac disease and autoimmune-associated conditions. Biomed Res Int (2013) 0.99

Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C. Hepatology (2008) 0.98

Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol (2005) 0.96

Microsurgical testis-sparing surgery in small testicular masses: seven years retrospective management and results. Urology (2012) 0.96

Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis (2011) 0.96

Genetic distinctions between autoimmune hepatitis in Italy and North America. World J Gastroenterol (2005) 0.95

Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors. Cancer Res (2012) 0.95

Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol (2003) 0.95

Bulbar urethroplasty with dorsal onlay buccal mucosal graft and fibrin glue. Eur Urol (2006) 0.95

Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis (2004) 0.95

Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis. Hepatol Res (2013) 0.95

High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease. Am J Gastroenterol (2002) 0.95

Open versus laparoscopic partial nephrectomy for clinical T1a renal masses: a matched-pair comparison of 280 patients with TRIFECTA outcomes (RECORd Project). World J Urol (2013) 0.94

Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. Am J Gastroenterol (2007) 0.94

Prevalence of celiac disease in multiple sclerosis. BMC Neurol (2011) 0.94

PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. Am J Gastroenterol (2009) 0.93

Mean platelet volume (MPV) increase during acute non-lacunar ischemic strokes. Thromb Res (2008) 0.92

Chronic endurance exercise training prevents aging-related cognitive decline in healthy older adults: a randomized controlled trial. Int J Geriatr Psychiatry (2010) 0.92

Retroperitoneal laparoendoscopic single-site surgery: preliminary experience in kidney and ureteral indications. Eur Urol (2010) 0.92

Adult patients with eosinophilic esophagitis do not show an increased frequency of the HLA-DQ2/DQ8 genotypes predisposing to celiac disease. Dig Dis Sci (2010) 0.92

Smooth muscle antibodies and type 1 autoimmune hepatitis. Autoimmunity (2002) 0.91

Detection of the M30 neoepitope as a new tool to quantify liver apoptosis: timing and patterns of positivity on frozen and paraffin-embedded sections. Am J Clin Pathol (2004) 0.91

NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system. Age (Dordr) (2011) 0.90

Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups. Clin Gastroenterol Hepatol (2012) 0.89